Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 12.87 CAD Market Closed
Market Cap: 147.7m CAD

Net Margin
Biosyent Inc

20.5%
Current
20%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.5%
=
Net Income
8.6m
/
Revenue
42.2m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CA
Biosyent Inc
XTSX:RX
144.9m CAD
20%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
491.8B USD
27%
CH
Roche Holding AG
SIX:ROG
271.4B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP
16%
US
Merck & Co Inc
NYSE:MRK
274.9B USD
30%
CH
Novartis AG
SIX:NOVN
218.8B CHF
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
-126%
US
Pfizer Inc
NYSE:PFE
144.9B USD
16%
No Stocks Found

Biosyent Inc
Glance View

Market Cap
144.9m CAD
Industry
Pharmaceuticals

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. BioSyent, through its wholly owned subsidiaries BioSyent Pharma Inc. (BioSyent Pharma) and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary of BioSyent, operates in the non-chemical insecticide business. BioSyent products include Combogesic, Aguettant System, Cathejell, Cysview, FeraMAX 150, FeraMAX Powder, Proktis-M, RepaGyn, and TIBELLA. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Aguettant System are used for a variety of injectable medications in hospitals and the acute care setting. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. RepaGyn for the healing of the vaginal mucosa and the treatment of vaginal dryness.

RX Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.5%
=
Net Income
8.6m
/
Revenue
42.2m
What is the Net Margin of Biosyent Inc?

Based on Biosyent Inc's most recent financial statements, the company has Net Margin of 20.5%.

Back to Top